Cross-Reactivity of tapentadol specimens with DRI methadone enzyme immunoassay

Journal of Analytical Toxicology

Volumn 36, Issue 8, 2012, Pages 582-587

  Collins, Ayodele A ^a   Merritt, A Paola ^a   Bourland, James A ^a  

^a Ameritox Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; ETHYLIDINE 1,5 DIMETHYL 3,3 DIPHENYLPYRROLIDINE; METHADONE; N DESMETHYLTAPENTADOL; TAPENTADOL; TAPENTADOL GLUCURONIDE; TAPENTADOL SULFATE; UNCLASSIFIED DRUG;

ANALYTICAL EQUIPMENT; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DRUG CROSS REACTIVITY; DRUG URINE LEVEL; ENZYME IMMUNOASSAY; FALSE POSITIVE RESULT; HUMAN; HUMAN TISSUE; PRESCRIPTION; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS;

EID: 84867681883     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bks064     Document Type: Article

References (17)

1. Microgenics DRI. (2003). Methadone Assay package insert. Microgenics Corporation, Fremont, CA
2. Microgenics DRI. (2006). Methadone Metabolite Assay package insert. Microgenics Corporation, Fremont, CA
3. Baselt, R.C. (2004), Disposition of toxic drugs and chemicals in man, 7th edition. Biomedical Publications, Foster City, CA pp. 678-681.
4. Shaikh, S., Hull, M.J., Bishop, K.A., Griggs, D.A., Long, W.H., Nixon, A.L. et al. (2008) Effect of tramadol use on three point-of-care and one instrument-based immunoassays for urine buprenorphine. Journal of Analytical Toxicology, 32, 339-343.
5. D'Nicuola, J., Jones, R., Levine, B., Smith, M.L. (1992) Evaluation of six commercial amphetamine and methamphetamine immunoassays for cross-reactivity to phenylpropanolamine and ephedrine in urine. Journal of Analytical Toxicology, 16, 211-213.
6. Logan, B.K., Costantino, A.G., Rieders, E.F., Sanders, D. (2010) Trazodone, meta-chlorophenylpiperazine (an hallucinogenic drug and Trazodone metabolite), and the hallucinogen trifluoromethylphenylpiperazine cross-react with the EMITw II Ecstasy immunoassay in urine. Journal of Analytical Toxicology, 34, 587-589.
7. Kovatsi, L., Pouliopoulos, A., Papadaki, A., Samanidou, V., Tsoukali, H. (2010) Development and validation of a high-performance liquid chromatography method for evaluation of niflumic acid crossreactivity of two commercial immunoassays for cannabinoids in urine. Journal of Analytical Toxicology, 34, 229-232.
8. Cody, J.T. (1990) Cross-reactivity of amphetamine analogues with roche abuscreen radioimmunoassay reagents. Journal of Analytical Toxicology, 14, 50-53.
9. (2009) Physicians' Desk Reference, 64th edition. PDR Network, LLC, Montvale, NJ, pp. 2643-2648.
10. Bourland, J.A. (2009) Schedules of controlled substances: Placement of tapentadol into schedule II. Final rule. Federal Register, 23790-23793.
11. Christoph, T., De Vry, J., Tzschentke, T.M. (2010) Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Neuroscience Letters, 470, 91-94.
12. Tzschentke, T.M., Jahnel, U., Kogel, B., Christoph, T., Englberger, W., De Vry, J. et al. (2009) Tapentadol hydrochloride: A next generation, centrally acting analgesic with two mechanisms of action in a single molecule. Drugs Today (Barcelona), 45, 483-496.
13. Terlinden, R., Ossig, J., Fliegart, F., Lange, C., Gohler, K. (2007) Absorption, metabolism and excretion of 14C-labeled tapentadol HCl in healthy male subjects. European Journal of Drug Metabolism and Pharmacokinetics, 32, 163-169.
14. Bourland, J.A., Collins, A.A., Chester, S.A., Ramachandran, S., Backer, R.C. (2010) Determination of tapentadol (Nucyntaw) and N-desmethyltapentadol in authentic urine specimens by ultraperformance liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology, 34, 450-457.
15. Levine, B. (2003) Principles of forensic toxicology, 2nd edition. AACC Press, Washington, DC, p. 136.
16. El-Haj, B., Al-Amri, A., Ali, H. (2008) Letter to the editor: crossreactivity of nefopam and its metabolites with benzodiazepine EMIT immunoassay. Journal of Analytical Toxicology, 32, 790-792.
17. Coulter, C., Taruc, M., Tuyay, J., Moore, C. (2010) Determination of tapentadol and its metabolite n-desmethyltapentadol in urine and oral fluid by liquid chromatography with tandem mass spectral detection. Journal of Analytical Toxicology, 34, 458-463.